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Purpose: Post-translational modification (PTM) of lens proteins is believed to play various roles in age-related lens
function and development. Among the different types of PTM, phosphorylation is most noteworthy to play a major role
in the regulation of various biosignaling pathways in relation to metabolic processes and cellular functions. The present
study reported the quantitative analysis of the in vivo phosphoproteomics profiles of human normal and cataractous lenses
with the aim of identifying specific phosphorylation sites which may provide insights into the physiologic significance
of phosphorylation in relation to cataract formation.
Methods:  To  improve  detection  sensitivity  of  low  abundant  proteins,  we  first  adopted  SDS-gel  electrophoresis
fractionation of lens extracts to identify and compare the protein compositions between normal and cataractous lenses,
followed by tryptic digestion, enrichment of phosphopeptides by immobilized metal affinity chromatography (IMAC)
and nano-liquid chromatography coupled tandem mass spectrometry (nanoLC-MS/MS) analysis.
Results: By comprehensively screening of the phosphoproteome in normal and cataractous lenses, we identified 32
phosphoproteins and 73 phosphorylated sites. The most abundantly phosphorylated proteins are two subunits of β-
crystallin, i.e., βB1-crystallin (12%) and βB2-crystallin (12%). Moreover, serine was found to be the most abundantly
phosphorylated residue (72%) in comparison with threonine (24%) and tyrosine (4%) in the lens phosphoproteome. The
quantitative analysis revealed significant and distinct changes of 19 phosphoproteins corresponding to 28 phosphorylated
sites between these two types of human lenses, including 20 newly discovered novel phosphorylation sites on lens proteins.
Conclusions: The shotgun phosphoproteomics approach to characterize protein phosphorylation may be adapted and
extended to the comprehensive analysis of other types of post-translational modification of lens proteins in vivo. The
identification of these novel phosphorylation sites in lens proteins that showed differential expression in the cataractous
lens may bear some unknown physiologic significance and provide insights into phosphorylation-related human eye
diseases, which warrant further investigation in the future.
Human eye lenses are composed of elongated fiber cells,
in which about 90% of total soluble proteins belong to three
major classes of proteins, i.e., α-, β- and γ-crystallins [1,2].
Essentially these crystallins can exist in the eye lens with little
turnover throughout the entire human lifespan albeit with
various  degrees  of  post-translational  modification  (PTM).
Various types of PTM have been identified in animal eye
lenses  including  especially  human  lenses,  e.g.:  1.
Deamidation  [3,4],  2.  Non-enzymatic  glycosylation  or
glycation [5,6], 3. Oxidation of some amino acid residues of
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lens  proteins  such  as  tryptophan  and  methionine  [7,8],  4.
Sulfhydryl-disulfide oxidation [9,10], 5. Acetylation of NH2-
terminal  and  lysine  residues  [11,12],  6.  Truncation  of
crystallins [13,14], and 7. Phosphorylation [15-23]. Among
these, phosphorylation is most noteworthy to play a major role
in the regulation of various biosignaling pathways in relation
to metabolic processes and cellular functions [24-26], which
may  include  cancer  development,  aging,  and  cataract
formation.  Therefore,  identification  of  protein
phosphorylation  and  its  exact  phosphorylated  residues  in
proteins or enzymes of interest are always considered as a
preeminent and nontrivial task in the conventional structural
and  functional  study  of  various  cellular  proteins.  Mainly
attributable  to  the  recent  advent  and  state-of-the-art
instrumentation of proteomics, the investigation of protein
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186phosphorylation has gradually become more amendable to
routine analysis.
The  recent  explosion  in  available  genomic  sequence
information is providing a useful sequence infrastructure for
proteomics database. A major aspect of various proteomics
strategies is the determination of protein identity (Protein ID)
using analytical ‘‘fingerprints’’ or peptide mass fingerprinting
(PMF)  generated  by  digestion  of  proteins  with  specific
enzymes such as trypsin, from which tandem mass (MS/MS)
spectra of peptide fragments can then be used for comparison
and  confirmation  of  protein  ID  in  available  sequence
databanks.  The  strategy  based  on  the  direct  analysis  of
peptides generated from protein digestion by high-resolution
liquid  chromatographies  coupled  with  tandem  MS/MS
spectrometry  has  facilitated  the  so-called  “shotgun
proteomics” for the identification of protein mixtures from
any  tissues  of  interest.  Various  MS/MS  spectra  can  be
algorithmically compared with predicted peptide spectra from
sequence databases to identify the respective proteins. By
combining  with  the  recent  development  of  capillary
multidimensional liquid chromatography (capillary-MDLC),
this shotgun proteomics approach is capable of characterizing
proteins directly from entire cell lysates [27-31]. In shotgun
proteomics,  MDLC  is  a  necessity  to  reduce  sample
complexity  and  increase  dynamic  range  of  protein
identification.  Recently  mass  spectrometric  methods  are
being developed along the line that not only identifies proteins
in a mixture but also compares the relative levels of protein
expression between two different samples, i.e., quantitative
shotgun proteomics.
The serious drawback of conventional gel-based 2-D gel
proteomics lies in low sensitivity and under-representation for
some special classes of proteins such as the extremely basic
or acidic groups of proteins and membrane proteins [32-34].
In  our  previous  study  [35],  phosphorylated  peptides  from
trypsin-digested total protein mixtures of porcine lenses were
concentrated  and  enriched  on  IMAC  followed  by
identification of phosphopeptides on μLC-MS/MS. Gel-free
IMAC phosphopeptide enrichment coupled with μLC-MS/
MS  analysis  was  found  to  be  capable  of  identifying
phosphorylated sites of various proteins from the whole lens
extract. In this study, we have further applied quantitative
shotgun  proteomics  to  study  and  compare  protein
phosphorylation between normal and cataractous lens extracts
to provide some basis to probe the role of phosphorylation in
relation to cataract formation in vivo.
METHODS
Materials  and  biologic  tissues:  Normal  (30-year-old)  and
cataractous  (68-year-old,  Grade  III  of  nuclear  sclerosis)
human  lenses  were  obtained  post  mortem  from  the
Department  of  Ophthalmology,  Chang  Gung  Memorial
Hospital, Taipei, Taiwan (J.-S. Lee). Eye lenses were kept and
stored at −80 °C freezer before dissection. Triethylammonium
bicarbonate  (TEABC)  and  iron  chloride  (FeCl3)  were
purchased from Sigma Aldrich (St. Louis, MO). The BCATM
protein-assay reagent kit was obtained from Pierce (Rockford,
IL).  Ammonium  persulfate  and  N,N,N’,N’-
tetramethylenediamine  were  purchased  from  Amersham
Pharmacia (Piscataway, NJ). Reagent-grade acetic acid (AA)
was  purchased  from  J.  T.  Baker  (Phillipsburg,  NJ).
Trifluoroacetic  acid  (TFA),  formic  acid  (FA)  and  HPLC-
grade  acetonitrile  were  purchased  from  Sigma  Aldrich.
Chemically-modified  and  sequencing-grade  trypsin  was
purchased from Promega (Madison, WI).
Preparation of lens extracts: Lenses were homogenized and
suspended in 20 mM Tris-HCl, pH 6.8 buffer containing 0.1%
SDS and centrifuged for 30 min at 20,000× g for the extraction
of total lens proteins as described previously [36-38].
1-D gel SDS–PAGE: After estimation of protein content by
using a BCATM protein-assay reagent kit (Pierce, Rockford,
IL), 10 μg of proteins in lens extracts were loaded on 12.5%
one-dimensional SDS–PAGE for protein separation, followed
by staining with Coomassie brilliant blue R-250 and destained
in 10% methanol/ 7% acetic acid.
In-gel digestion and nanoLC-ESI-MS/MS: Based on the SDS–
PAGE analysis of samples, differentially expressed proteins
were selected for further identification by nanoLC-MS/MS.
The protein bands separated on 1-D SDS–PAGE were cut
from  gels,  and  then  destained  three  times  with  25  mM
ammonium bicarbonate buffer (pH 8.0) in 50% acetonitrile
(ACN) for 1 h. The gel pieces were dehydrated in 100% ACN
for 5 min and then dried for 30 min in a vacuum centrifuge.
Enzyme digestion was performed by adding 0.5 μg trypsin in
25 mM ammonium bicarbonate buffer per sample at 37 °C for
16 h. The peptide fragments were extracted twice with 50 μl
50% ACN/ 0.1% TFA. After removal of ACN and TFA by
centrifugation in a vacuum centrifuge, samples were dissolved
in 0.1% formic acid/ 50% ACN and analyzed by nanoLC-ESI-
MS/MS  at  the  core  facility  laboratory  of  the  Center  for
Research Resources and Development, Kaohsiung Kaohsiung
Medical University, Kaohsiung, Taiwan and at Institute of
Chemistry, Academia Sinica, Taipei, Taiwan. Proteins were
identified in the NCBI databases by use of MS/MS ion search
with the search program MASCOT as described previously
[35].
Gel-assisted digestion: The protein samples from lenses were
subjected  to  gel-assisted  digestion.  The  sample  was
incorporated into a gel directly in an Eppendorf vial with
acrylamide/bisacrylamide solution (40%, v/v, 29:1), 10% (w/
v) APS, 100% TEMED in a proportion of 14:5:0.7:0.3. The
gel was cut into small pieces and washed several times with
25 mM TEABC containing 50% (v/v) ACN. The gel samples
were further dehydrated with 100% ACN and completely
dried using a SpeedVac (ASAHI TECHNO GLASS Corp.,
Tokyo, Japan). Proteolytic digestion was then performed with
trypsin (protein: trypsin=50:1, w/w [g/g]) in 25 mM TEABC
Molecular Vision 2011; 17:186-198 <http://www.molvis.org/molvis/v17/a23> © 2011 Molecular Vision
187with incubation overnight at 37 °C. The tryptic peptides were
dried completely under vacuum and stored at −30 °C.
IMAC  preparation  and  protocol:  This  step  of  sample
preparation and procedure is most critical for a successful
phosphoproteomics  study  of  complex  protein  mixtures
isolated from biologic tissues. The IMAC column was first
capped one end with a 0.5 μm frit disk enclosed in stainless
steel  column-end  fitting.  The  Ni-nitrilotriacetic  acid  (Ni-
NTA) resin was extracted from spin column (Qiagen, Hilden,
Germany) and packed into a 10-cm microcolumn (500 μm i.d.
PEEK column, Upchurch Scientific/Rheodyne, Oak Harbor,
WA) as described previously [39]. Automatic purification of
phosphopeptides  was  performed  by  connecting  to  an
autosampler in an HP1100 solvent delivery system (Hewlett-
Packard, Palo Alto, CA) with a flow rate 13 µl/min. First, the
Ni2+ ions were removed with 100 µl 50 mM EDTA in 1 M
NaCl. Then the IMAC column was activated with 100 µl 0.2
M FeCl3 and equilibrated with loading buffer for 30 min
before sample loading. The loading buffer/ acetic acid was 6%
(v/v)  and  the  pH  was  adjusted  to  3.0  with  0.1  M  NaOH
(pH=12.8). The peptide samples from trypsin digestion were
reconstituted in the loading buffer and loaded into the IMAC
column  that  had  been  equilibrated  with  the  same  loading
buffer for 20 min. Then the unbound peptides were removed
with 100 μl washing solution consisting of 75% (v/v) loading
buffer and 25% (v/v) ACN, followed by equilibration with
loading buffer for 15 min. Finally, the bound peptides were
eluted  with  100  µl  200  mM  NH4H2PO4  (pH  4.4).  Eluted
peptide  samples  were  dried  under  vacuum  and  then
reconstituted in 0.1% (v/v) TFA (40 μl) for further desalting
and concentration using ZipTipsTM (Millipore, Bedford, CA).
NanoLC-MS/MS analysis: Purified phosphopeptide samples
from about 500 µg total protein extract were reconstituted in
4 µl buffer A (0.1% formic acid (FA) in H2O) and analyzed
by LC-Q-TOF MS (Waters Q-TOFTM Premier; Waters Corp,
Milford,  MA).  For  LC-MS/MS  analysis  by  Waters  Q-
TOFTM  Premier  system,  samples  were  injected  into  a  2
cm×180  μm  capillary  trap  column  and  separated  by  20
cm×75 μm Waters1 ACQUITYTM 1.7 mm BEH C18 column
using  a  nanoACQUITY  Ultra  Performance  LCTM  system
(Waters Corp., Milford, MA). The column was maintained at
35 °C and bound peptides were eluted with a linear gradient
of 0%–80% buffer B (buffer A, 0.1% FA in H2O; buffer B,
0.1% FA in ACN) for 120 min. MS was operated in ESI
positive  V  mode  with  a  resolving  power  of  10,000.
NanoLockSpray  source  was  used  for  accurate  mass
measurement and the lock mass channel was sampled every
30 s. The mass spectrometer was calibrated with a synthetic
human  [Glu1]-fibrinopeptide  B  solution  (1  pmol/µl,  from
Sigma  Aldrich)  delivered  through  the  NanoLockSpray
source. Data acquisition was operated in the data directed
analysis (DDA). The method included a full MS scan (m/z
400–1600, 0.6 s) and 3 MS/MS scans (m/z 100–1990, 1.2 s
each scan) sequentially on the three most intense ions present
in the full scan mass spectrum.
Database search and data processing/filtering: Raw MS/MS
data were converted into peak lists using Distiller (version 2.0;
Matrix Science, London, UK) with default parameters. All
MS/MS samples were analyzed using Mascot (version 2.2.1;
Matrix  Science).  Mascot  was  set  up  to  search  the
Swissprot_Mammalia (version 54.2, 55307 entries) assuming
trypsin as the digestion enzyme. MASCOT was searched with
a fragment ion mass tolerance of 0.1 Da and a parent ion
tolerance of 0.1 Da. Two missed cleavages were allowed for
trypsin  digestion.  Phosphorylation  (Ser/Thr/Tyr)  and
oxidation (Met) were selected as two variable modifications.
To evaluate the false discovery rate of protein identification,
we repeated the search using identical search parameters and
validation  criteria  against  a  randomized  decoy  database
created  by  MASCOT.  The  false  discovery  rates  with
MASCOT  score  >36  (p<0.05)  was  0.73%  in  our
phosphoproteomics study of lens protein extracts.
Label-free quantitation method: The quantitative analysis of
peptides  in  the  label-free  experiments  was  performed  by
employing our recently published software, IDEAL-Q [40,
41].  The  raw  data  files  acquired  from  Waters  Q-TOFTM
Premier were converted into files of mzXML format by the
program massWolf, and the search results in MASCOT were
exported in eXtensive Markup Language data (.XML) format.
After data conversion, the confident peptide identification
results (p<0.05) from each LC-MS/MS run were loaded and
merged  to  establish  a  global  peptide  information  list
(sequence, elution time, and mass-to-charge). Alignment of
elution  time  is  then  performed  based  on  the  peptide
information list using linear regression in different LC-MS/
MS  runs  followed  by  correction  of  aberrational
chromatographic  shift  across  fragmental  elution-time
domains. To calculate relative peptide abundance, the tool
performs  reconstruction  of  extracted  ion  chromatography
(XIC), and calculation of XIC area. The fold-change of a given
peptide  was  calculated  by  the  ratio  of  relative  peptide
abundance between different samples.
RESULTS AND DISCUSSION
In spite of the biologic significance and physiologic role of
protein  phosphorylation  and  the  rapid  advances  in  MS
methodologies,  high-throughput  characterization  of  site-
specific  phosphorylation  residues  in  proteins  is  still
challenged  by  the  technical  difficulties  [42,43]  associated
with their dynamic modification patterns, substoichiometric
concentrations, heterogeneous forms of phosphoproteins, and
low sensitivity and response from MS analyses of total protein
mixtures extracted from biologic tissues. Therefore improved
methodologies  that  specifically  enrich  the  transient
phosphoproteome in a routine and comprehensive manner are
important  for  studying  phosphorylation-dependent  cellular
signaling associated with various diseased states [44].
Molecular Vision 2011; 17:186-198 <http://www.molvis.org/molvis/v17/a23> © 2011 Molecular Vision
188Experimental  design  and  methodology  evaluation:
Identification of large numbers of phosphopeptides with high
specificity,  reproducibility  and  recovery  is  critical  in
phosphoproteomics analysis. IMAC takes advantage of the
phosphate groups as electron donors that chelate metal ion
(Fe3+-NTA-silica) to preferentially retain phosphopeptides.
Although  the  simple  and  routinely  used  protocol  yields
adequate  results  for  simple  phosphoprotein  mixtures,  the
results for proteome-wide analysis are far from satisfactory.
As  shown  previously  [35,39],  we  have  found  the  IMAC
protocol used herein can yield an efficient enrichment and
obtain specific purification for phosphopeptides devoid of
contamination (a lack of nonspecific competitive binding).
The pH effect for the binding and elution of phosphopeptides
in  IMAC  protocol  has  been  critically  evaluated,
demonstrating that the current IMAC method can reflect the
representative phosphorylated amino-acid distribution such as
phosphotyrosine, phosphoserine and phosphothreonine in the
cell  without  bias.  To  date,  the  specificity  and  recovery
reported in our IMAC protocol significantly exceed those
previously  achieved  by  single-step  IMAC  or  IMAC  in
combination  with  methylation  [45].  This  protocol
demonstrated  high  specificity  (98%)  that  was  comparable
with TiO2 chromatography [46,47]. As compared to two-step
purification  methods,  our  protocol  provides  comparable
selectivity and low sample loss with some advantages over
current procedures. In terms of practical use, it offers a simple
one-step, more reproducible method amenable to automatic
phosphopeptide  purification  and  enrichment  using  a  Fe3+-
IMAC microcolumn. Greater than 90% column recovery and
enrichment specificity can be routinely achieved for single
IMAC purification of up to 1 mg of protein lysates from
various cell lines or tissues.
Gel-based 1D- or 2D-gel proteomics: In 1993, Henzel et
al.  [48]  first  reported  and  started  the  popular  gel-based
proteomics analysis by combining 2D-gel electrophoresis and
mass spectrometry. The global identification of proteins in
biologic samples was based on pre-separation of a protein
mixture on 2-D gel electrophoresis. The mass spectral patterns
from tandem mass (MS/MS) analysis of protein fragments
generated from protease digestion were then compared with
predicted peptide spectra from sequence databases to identify
the  respective  proteins.  Although  previously  2-D  gel
electrophoresis coupled with tandem MS has been considered
as the method of choice in proteomics study, only up to 2,000
individual polypeptide chains at most can be resolved on a
single 2-D gel [31]. The number of detected proteins is still
being relatively small as compared to the whole genome-
encoded functional proteins of about 20,000~30,000 in higher
vertebrates.  It  is  especially  under-representative  of  some
special  classes  of  proteins  such  as  low-abundance
transcription factors and membrane proteins [32-34] because
of the low solubility of these classes of proteins in the first
dimensional isoelectric-focusing (IEF) protein separation of
2-D gel electrophoresis in the absence of SDS denaturing
agent. In our proteomic study of porcine lens proteins [35],
we have also encountered poor solubility of some proteins in
pre-MS 2-D gel separation.
To improve the detection sensitivity for low abundant
proteins, fractionation was first performed for the total protein
extracts of normal and cataractous human lenses by 1-D SDS–
PAGE gels (Figure 1). The proteins were separated into at
least more than 10 different protein bands or zones from total
protein mixtures of normal and cataract lenses. In comparison
with  normal  human  lens-proteome,  only  four  crystallin
proteins, i.e., β-crystallin B1, β-crystallin B2, βs-crystallin
B1, and γD-crystallin in cataractous lens showed significant
decrease in their expression levels. Similar results in previous
reports  also  pointed  to  the  important  role  of  differential
crystallin expression leading to cataract formation [49-51]. It
can be seen that 1-D gels are less tedious and time-consuming
than 2-D gels and still afford a respectable and extensive
protein separation capable of protein ID analysis after LC-
MS/MS.  The  unambiguous  identification  of  some  major
classes  of  β-  and  γ-crystallin  classes  were  confirmed  and
verified in addition to α-crystallins reported previously [35].
However, similar to the previous 2-D gel phosphoproteomic
study of α-crystallins, the phosphorylated sites identified by
1-D gel-based methodology are still very limited; only a few
well known abundant and predominant sites such as Ser-59,
Ser-81  and  Ser-155  in  αA-crystallin,  Ser-19,  Ser-21  and
Ser-59 in αB-crystallin, and Thr-189, Ser-9 and Ser-95 in
βB1-crystallin were identified [35]. We could not find any
other  phosphopeptides  in  trypsin-digested  protein  bands
corresponding to other lens proteins when using the 1-D or 2-
D  gel  approach  probably  due  to  lower  abundance  of
phosphopeptides generated from digestion of protein bands.
Therefore  we  have  resorted  to  the  newer  strategy  of
quantitative  shotgun  proteomics  by  using  IMAC  for  the
enrichment of phosphopeptides generated from the protease
digestion of total lens extracts.
Gel-free proteomic analysis of phosphorylated proteins
in  human  lenses:  Because  the  capability  of  a  gel-based
proteomic approach to identify phosphoproteins was limited
for phosphopeptide identification, we adopted instead a gel-
free protocol similar to shotgun proteomic approaches [28,
29]. By enrichment of the lens phosphopeptides on IMAC
followed  by  LC-MS/MS  analysis,  we  have  identified  73
phosphorylation sites in human lens proteins (Table 1). As
shown  in  Table  1,  the  identified  172  nondegenerate
phosphopeptides belonged to 32 proteins in the human lens,
including 9 crystallin proteins and other non-crystallin lens
proteins possessing different cellular functions. Among the
identified  phosphoproteins,  the  relative  proportions  of  the
corresponding  proteins  with  functions  relating  to  protein
folding, metabolism and cytoskeleton were 32%, 28%, and
25%, respectively (Figure 2). The other 15% phosphoproteins
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cellular redox system and homeostasis.
As shown in Figure 3A, further analysis of the whole
phosphoproteome  in  human  lenses  indicated  that
phosphorylation on serine (72%) was more common than that
on threonine (24%) and tyrosine (4%). In Figure 3B, most
phosphopeptides were identified as being crystallin proteins,
indicating that the major classes of lens crystallins are also the
most abundant phosphoproteins in the human lens tissue. The
proportions  of  phosphopeptides  identified  as  being  βB1-
crystallin,  βB2-crystallin,  αB-crystallin,  γD-crystallin,
filensin, αA-crystallin, and βs-crystallin were 12%, 12%, 9%,
8%, 8%, 6%, and 6%, respectively, emphasizing the fact that
βB-crystallin subunits are indeed the major phosphorylation
targets in the lens and may play a significant role in the
phosphorylation-related  biosignaling  function  in  this
transparent lens tissue.
Identification  of  phosphorylation  sites  in  human  lens
crystallins: As shown in Table 1, the phosphorylation sites of
crystallin  proteins  were  found  to  spread  over  the  entire
polypeptide  regions  of  these  crystallins.  Based  on  the
proportion  of  phosphorylation  sites  in  each  crystallin,  we
found that Ser-81 (31%) and Ser93/Thr-118 (25%) are the
predominant  phosphorylation-sites  in  βB1-  and  βB2-
crystallin,  respectively  (Figure  4A,B).  In  addition,  the
phosphorylation  of  αB-crystallin  was  shown  to  distribute
evenly over the whole crystallin molecule at Ser-19 (23%),
Ser-21 (22%), Ser-59 (22%), and Ser-139 (22%; Figure 4C)
similar to our previous report on porcine αB-crystallin [35].
In contrast, some predominant phosphorylation sites present
in other crystallin proteins were also identified, e.g., Ser-75
(50%) in γD-crystallin, Thr-148 (33%) in αA-crystallin, and
Tyr-11/Ser-167 (33%) in β-crystallin S (also denoted as βs-
crystallin).  The  mechanisms  underlying  the  differential
phosphorylation at specific sites of these crystallins remain
unknown, which should be of interest for further study in the
future.
Identification of phosphorylation sites in non-crystallin
proteins involved in cytoskeleton, metabolism, transport, and
cellular redox homeostasis: In addition to 9 lens crystallins,
23  non-crystallin  proteins  were  also  found  to  be
phosphorylated  in  vivo  in  our  phosphoproteomic  analysis
(Table 1). It is noteworthy that similar to αB-crystallin (a
member of the small heat-shock protein family in the lens),
Figure  1.  Comparative  analysis  of
normal  and  cataractous  human  lens
proteins  by  SDS–PAGE  followed  by
LC-nanoESI-MS/MS. As shown in the
left panel, a total of 10 μg lens proteins
derived  from  normal  (N)  and
cataractous (P) eye lenses were resolved
with  12.5%  SDS–PAGE  and  stained
with Coomassie brilliant blue R-250. In
the  right  panel,  protein  and  peptide
bands with different expression levels
identified by LC-nanoESI-MS/MS were
indicated by arrows. In comparison with
normal  human  lens  proteome,  four
crystallin proteins, β-crystallin B1, β-
crystallin  B2,  βs-crystallin,  and  γD-
crystallin in the cataract lens were found
to significantly decrease in expression
levels as compared to normal lens.
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192another heat-shock protein beta-1 (homolog of heat-shock
proteins  Hsp27  and  Hsp20)  with  chaperone  activity  was
shown to be phosphorylated at Ser-82 [52,53]. To date these
phosphorylated sites in the non-crystallin proteins have never
been identified in the lens tissue and warranted for detailed
functional characterization in the future.
Comparative  analysis  of  phosphoproteome  in  human
lenses with or without cataract: To investigate the differential
post-translational modification of human lens proteins with or
without  cataract,  we  performed  quantitative
phosphoproteomic  analysis.  As  shown  in  Table  2,  19
phosphoproteins consisting of 8 crystallin proteins and 11
non-crystallin  proteins  with  their  corresponding  28
phosphorylated sites were identified between these two types
of human lenses. Among these identified proteins, the extents
of 15 phosphorylated sites were found to increase by twofold
while 13 sites decreased in phosphorylation, indicating that
complicated  post-translational  modification  such  as
phosphorylation  may  be  one  of  the  causative  factors
underlying the development of human cataract. Furthermore,
some quantitative changes in the phosphorylation status were
found even in the same proteins from normal and diseased
lenses such as βB1-crystallin and αB-crystallin. In human
cataractous lenses, two phosphorylated sites in βB1-crystallin,
Ser-32  and  Ser-81,  were  found  to  decrease  while  Ser-93
increased in their relative phosphorylation ratios (P/N ratio in
Table 2). The different proportions of phosphorylation and
specific  phosphorylated  sites  associated  with  normal  and
Figure  2.  The  percent  distribution  of
annotated  functions  for  identified
phosphoproteins  in  normal  human
lenses. After being identified by using
gel-free  IMAC  phosphopeptide
enrichment  and  LC-MS/MS  analysis,
phosphoproteins  were  classified  into
five functional categories annotated in
the  proteomic  databank.  The
proportions  of  annotated  functions
related to protein folding, metabolism,
and cytoskeleton were 32%, 28%, and
25%,  respectively.  The  other  15%
identified proteins belonged to protein
families  of  transport,  cellular  redox
homeostasis,  and  other  unidentified
functions.
Figure  3.  The  percent  distribution  of
phosphorylated sites in normal human
lens proteins identified by using gel-free
IMAC phosphopeptide enrichment and
LC-MS/MS analysis. A: Proportions of
three  different  phosphorylated  amino-
acid  residues  (Ser/Thr/Tyr)  in  normal
human lens extract. Phosphorylation on
serine (72%) was more common than
threonine (24%) and tyrosine (4%). B:
Proportions  of  the  identified  proteins
with phosphorylation in normal human
lens  proteins.  The  proportions  of
phosphopeptides  identified  in  βB1-
crystallin, βB2-crystallin, αB-crystallin,
γD-crystallin,  filensin,  αA-crystallin,
and  β-crystallin  S  (or  denoted  as  βs-
crystallin)  were  12%,  12%,  9%,  8%,
8%, 6%, and 6%, respectively.
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193cataractous human lens proteins may form a firm basis for
unraveling the mechanistic pathways of cataract formation
with aging. Furthermore, among the differentially expressed
phosphopeptides, 20 phosphorylation sites were verified to be
newly  discovered  based  on  comparison  with  those  in  the
phosphoprotein  databases,  Uni-Prot  and  PhosphoSitePlus*
website. The data also revealed 14 novel phosphorylation sites
on  7  crystallin  proteins.  These  differentially  expressed
phosphorylation  and  their  associated  phosphorylated  sites
might be the potential therapeutic targets of cataract disease,
which warrant further investigation.
Conclusions:  The  conventional  gel-based
phosphoproteomics  analyses  by  1-D  SDS–PAGE  coupled
LC-MS/MS  and  separately  by  IMAC  enrichment  of
phosphopeptides followed by shotgun label-free quantitation
method  have  been  used  to  analyze  and  compare
phosphorylation patterns of lens proteins from whole tissue
extracts of normal and cataractous lenses. In this report we
have  focused  on  employing  efficient  IMAC  protocol  of
phosphopeptide  enrichment  for  profiling  and  quantitative
analysis of transiently phosphorylated proteins. The IMAC
protocol reported herein demonstrated enrichment with high
specificity and low sample loss without the need for additional
esterification  and  desalting  step.  This  procedure  may  be
applicable to a variety of materials such as tissue, cell and
body fluid. As judged by the higher sample recovery and
greater number of phosphopeptides identified by the critically
validated IMAC procedure [35,39] in this study as compared
to  previous  reports  on  phosphorylation  analysis  in  the
literature  [4,15-18,54,55],  it  should  prove  feasible  for  the
routine  phosphoproteome  analysis  in  the  future.  The
combination of this protocol with either stable isotope tagging
or a label-free methodology may be further employed for
large-scale  comparative  proteomic  studies  to  decipher  the
dynamic and complicated phosphoproteomes from various
biologic samples of diverse tissues. On the other hand, the
identification  of  these  novel  phosphorylation  sites  in  lens
proteins that showed differential expression in the cataractous
lens may bear some as-yet-unknown physiologic significance
Figure  4.  The  percent  distribution  of
phosphorylation sites of phosphorylated
crystallin proteins in normal human lens
proteins.  Distribution  of  in  vivo
phosphorylation  sites  in  A:  βB1-
crystallin;  B:  βB2-crystallin;  C:  αB-
crystallin;  D:  γD  -crystallin;  E:  αA-
crystallin; and F: βS-crystallin. Ser-81
(31%) and Ser93/Thr-118 (25%) are the
predominant  phosphorylation-sites  in
βB1-crystallin  and  βB2-crystallin,
respectively.  In  addition,  the
phosphorylation  of  αB-crystallin  was
shown to distribute almost evenly over
the whole crystallin molecule at Ser-19
(23%), Ser-21 (22%), Ser-59 (22%), and
Ser-139 (22%). In contrast, there was at
least one predominant phosphorylated
site  in  other  crystallin  proteins,  i.e.,
Ser-75 (50%) in γD-crystallin, Thr-148
(33%)  in  αA-crystallin,  and  Tyr-11/
Ser-167 (33%) in βS-crystallin.
Molecular Vision 2011; 17:186-198 <http://www.molvis.org/molvis/v17/a23> © 2011 Molecular Vision
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195and provide insights into phosphorylation-related human eye
diseases.
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